Patent · US Active

Methods for modulating IKKα activity

US8088915B2 · kind B2 · utility

0Cited by

6References

3Claims

0Family size

Assignee

Boehringer Ingelheim Pharmaceuticals, Inc. · US

Inventors

Jun Li · Greenville, US
Xiang Li · Beijing, CN
Jianfei Yang · Sandy Hook, US
Kenneth Marcu · Stony Brook, US

Key dates

Filing date	Oct 13, 2010
Grant date	Jan 3, 2012
Priority date	—
Expiry date	Oct 13, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for modulating NF-κB dependent gene transcription in a cell comprised of modulating IKKα protein activity in the cell. The present invention also provides siRNA compositions and methods thereof for modulating NF-κB dependent gene transcription.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.